[go: up one dir, main page]

EP2086527A4 - Systèmes destinés à mettre fin à l'usage du tabac - Google Patents

Systèmes destinés à mettre fin à l'usage du tabac

Info

Publication number
EP2086527A4
EP2086527A4 EP07867592A EP07867592A EP2086527A4 EP 2086527 A4 EP2086527 A4 EP 2086527A4 EP 07867592 A EP07867592 A EP 07867592A EP 07867592 A EP07867592 A EP 07867592A EP 2086527 A4 EP2086527 A4 EP 2086527A4
Authority
EP
European Patent Office
Prior art keywords
systems
tobacco use
effecting cessation
cessation
effecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07867592A
Other languages
German (de)
English (en)
Other versions
EP2086527A2 (fr
Inventor
Igor Gonda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aradigm Corp
Original Assignee
Aradigm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/931,867 external-priority patent/US20080138398A1/en
Priority claimed from US11/932,402 external-priority patent/US20080138294A1/en
Priority claimed from US11/932,437 external-priority patent/US8256433B2/en
Priority claimed from US11/931,921 external-priority patent/US20080138399A1/en
Application filed by Aradigm Corp filed Critical Aradigm Corp
Publication of EP2086527A2 publication Critical patent/EP2086527A2/fr
Publication of EP2086527A4 publication Critical patent/EP2086527A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
EP07867592A 2006-12-01 2007-11-30 Systèmes destinés à mettre fin à l'usage du tabac Withdrawn EP2086527A4 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US86823806P 2006-12-01 2006-12-01
US91104407P 2007-04-10 2007-04-10
US91318507P 2007-04-20 2007-04-20
US91651007P 2007-05-07 2007-05-07
US91719007P 2007-05-10 2007-05-10
US98207007P 2007-10-23 2007-10-23
US11/931,867 US20080138398A1 (en) 1999-07-16 2007-10-31 Dual release nicotine formulations, and systems and methods for their use
US11/932,402 US20080138294A1 (en) 1999-07-16 2007-10-31 Systems and methods for effecting cessation of tobacco use
US11/932,437 US8256433B2 (en) 1999-07-16 2007-10-31 Systems and methods for effecting cessation of tobacco use
US11/931,921 US20080138399A1 (en) 1999-07-16 2007-10-31 Dual release nicotine formulations, and systems and methods for their use
PCT/US2007/024641 WO2008069972A2 (fr) 2006-12-01 2007-11-30 Systèmes destinés à mettre fin à l'usage du tabac

Publications (2)

Publication Number Publication Date
EP2086527A2 EP2086527A2 (fr) 2009-08-12
EP2086527A4 true EP2086527A4 (fr) 2010-03-03

Family

ID=39492806

Family Applications (2)

Application Number Title Priority Date Filing Date
EP07867592A Withdrawn EP2086527A4 (fr) 2006-12-01 2007-11-30 Systèmes destinés à mettre fin à l'usage du tabac
EP07867591A Withdrawn EP2086317A4 (fr) 2006-12-01 2007-11-30 Formulations de nicotine, trousses, systèmes et procédés d'utilisation

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP07867591A Withdrawn EP2086317A4 (fr) 2006-12-01 2007-11-30 Formulations de nicotine, trousses, systèmes et procédés d'utilisation

Country Status (2)

Country Link
EP (2) EP2086527A4 (fr)
WO (2) WO2008069972A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP2012517402A (ja) * 2009-02-11 2012-08-02 ヘグルンド、エー．エス． 禁煙を目的としたニコチンを頬側吸収するための組成物
WO2011023796A1 (fr) * 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox destiné au traitement de l'addiction
TWI484958B (zh) * 2011-05-19 2015-05-21 Heglund A S 用於戒菸之口腔吸收尼古丁組成物
EP2729148A4 (fr) 2011-07-06 2015-04-22 Parkinson S Inst Compositions et méthodes de traitement de symptômes chez des patients atteints de la maladie de parkinson
RU2541312C2 (ru) * 2011-08-31 2015-02-10 Александр Васильевич Иващенко Фармацевтическая композиция, способ ее получения и устройство для ее применения
US10556011B2 (en) * 2011-12-02 2020-02-11 Joshua D. Levine Method and system for adding sensory conditioning cues in a pharmacotherapeutic regimen
US10034988B2 (en) 2012-11-28 2018-07-31 Fontem Holdings I B.V. Methods and devices for compound delivery
WO2015042412A1 (fr) 2013-09-20 2015-03-26 E-Nicotine Technology. Inc. Dispositifs et procédés de modification de dispositifs de distribution
CA2974324A1 (fr) 2015-01-28 2016-08-04 Zita S. Netzel Procedes et systemes d'administration de medicament
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US11224594B2 (en) 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
US20170071248A1 (en) 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
CA3049529A1 (fr) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Dispositifs et methodes d'administration transdermique de medicament
CN110300588A (zh) * 2017-03-07 2019-10-01 菲利普莫里斯生产公司 可吸入尼古丁调配物及其制造和使用方法
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817860D0 (en) 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
EP3880175A4 (fr) 2018-11-16 2022-08-17 Morningside Venture Investments Limited Système d'administration transdermique de médicaments à régulation thermique
JP7551621B2 (ja) 2018-12-28 2024-09-17 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 低モル質量金属塩を含む液体ニコチン製剤

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0557129A1 (fr) * 1992-02-20 1993-08-25 Johannes Louw Kotze Von Wielligh Produit pour assister un fumeur à cesser cet habitude
WO1994027576A1 (fr) * 1993-05-20 1994-12-08 Danbiosyst Uk Limited Composition d'administration par voie nasale d'un medicament, contenant de la nicotine
US5721257A (en) * 1993-08-04 1998-02-24 Pharmacia & Upjohn Ab Method and therapeutic system for smoking cessation
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
US6024097A (en) * 1992-02-20 2000-02-15 J Mom Trust Product for assisting a smoker in giving up the habit
WO2001005459A1 (fr) * 1999-07-16 2001-01-25 Aradigm Corporation Systeme permettant d'arreter de fumer
WO2003097146A1 (fr) * 2002-05-15 2003-11-27 Aradigm Corporation Systeme pour cesser de fumer
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070100000A1 (en) * 2000-11-01 2007-05-03 Epstein Mel H Methods of providing neuroprotection
US6759435B1 (en) * 2003-07-03 2004-07-06 A.P. Group Inc. Antidepressant drugs and methods

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0557129A1 (fr) * 1992-02-20 1993-08-25 Johannes Louw Kotze Von Wielligh Produit pour assister un fumeur à cesser cet habitude
US6024097A (en) * 1992-02-20 2000-02-15 J Mom Trust Product for assisting a smoker in giving up the habit
WO1994027576A1 (fr) * 1993-05-20 1994-12-08 Danbiosyst Uk Limited Composition d'administration par voie nasale d'un medicament, contenant de la nicotine
US5721257A (en) * 1993-08-04 1998-02-24 Pharmacia & Upjohn Ab Method and therapeutic system for smoking cessation
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
WO2001005459A1 (fr) * 1999-07-16 2001-01-25 Aradigm Corporation Systeme permettant d'arreter de fumer
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
WO2003097146A1 (fr) * 2002-05-15 2003-11-27 Aradigm Corporation Systeme pour cesser de fumer

Also Published As

Publication number Publication date
WO2008069970A3 (fr) 2008-10-16
WO2008069972A3 (fr) 2008-10-30
EP2086317A4 (fr) 2010-03-03
WO2008069972A2 (fr) 2008-06-12
WO2008069970A2 (fr) 2008-06-12
EP2086317A2 (fr) 2009-08-12
EP2086527A2 (fr) 2009-08-12

Similar Documents

Publication Publication Date Title
EP2086527A4 (fr) Systèmes destinés à mettre fin à l'usage du tabac
AP2760A (en) Cigarette substitute
ZA200808966B (en) Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
PL2402319T3 (pl) Inhibitory DGAT
IL195010A0 (en) Bicyclic derivatives as cetp inhibitors
IL195792A0 (en) Amino-piperidine derivatives as cetp inhibitors
ZA200906946B (en) Inhibitors of iap
EP1993539A4 (fr) Thiazolones utilisés en tant qu'inhibiteurs de p13-kinases
IL198777A0 (en) Smoking article filter
EP2015745A4 (fr) Inhibiteurs de kinase macrocycliques
IL198791A (en) Arterial occlusion systems
EP1993535A4 (fr) Thiazolones utilisés en tant qu'inhibiteurs de p13-kinases
IL194494A0 (en) Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors
IL196000A0 (en) 2-arylindole derivatives as npges-i inhibitors
EP1993536A4 (fr) Thiazolones utilisés en tant qu'inhibiteurs de p13-kinases
EP1993537A4 (fr) Thiazolones utilisés en tant qu'inhibiteurs de p13-kinases
EP1996191A4 (fr) Thiazolones utilisés en tant qu'inhibiteurs de p13-kinases
HRP20130813T1 (hr) Sredstvo za odvikavanje od pušenja
IL197981A0 (en) Kinase inhibitors
GB0616575D0 (en) Additive system
EP1993538A4 (fr) Thiazolones utilisés en tant qu'inhibiteurs de p13-kinases
HK1128245A (en) Systems for effecting cessation of tobacco use
ZA200810008B (en) Amino-piperidine derivatives as CETP inhibitors
GB0608157D0 (en) Smoking alternative-inhalaton device
GB0608822D0 (en) Inhibitors of DHFR

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090529

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: GONDA, IGOR

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1128245

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20100203

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/465 20060101ALI20100128BHEP

Ipc: A61K 31/135 20060101AFI20100128BHEP

Ipc: A61P 25/34 20060101ALI20100128BHEP

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20100503

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150904

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1128245

Country of ref document: HK